HPV16/18E6、端粒酶、周期素D1在鼻咽癌细胞中的表达检测

详细信息    查看官网全文

• 论文作者：吕彩凤 ; 孙永东
• 年：2016
• 作者机构：西南医科大学附属中医医院耳鼻喉科;
• 论文关键词：鼻咽癌HNE1细胞 ; HPV16/18E6 ; 端粒酶 ; 周期素D1
• 英文论文关键词：HNE-1 cell ; HPV16/18E6 ; telomerase ; cyclin D1
• 会议召开时间：2016-11-25
• 会议录名称：湖南中医药大学学报2016/专集：国际数字医学会数字中医药分会成立大会暨首届数字中医药学术交流会论文集
• 语种：中文
• 分类号：R739.63
• 学会代码：HNZY
• 会议名称：国际数字医学会数字中医药分会成立大会暨首届数字中医药学术交流会
• 会议地点：中国广东珠海
• 主办单位：国际数字医学会、Digital Chinese Medicine
• 学会名称：湖南中医药大学期刊杂志社
• 页数：2
• 文件大小：2059k
• 原文格式：D
• 会议级别：全国

摘要

目的探讨HPV16/18E6、端粒酶(telomerase)、周期素D1(cyclin D1)这三种指标在鼻咽癌HNE1细胞中的表达及意义。方法以PBS作为阴性对照,把被过氧化物酶标记的链霉卵蛋白素放置在细胞爬片上进行检测。结果三种指标在鼻咽癌HNE1细胞中均为阳性表达。结论提示上述三种指标与鼻咽癌的发生发展有密切关系。
Objective To detect expression of HPV16/18E6、telomerase and cyclin D1 in nasopharyngeal carcinoma.Methods streptavidin/peroxidase were applied to examine. Resultsand conclusions positive resultions were showed, which suggest that three of all are highly related to nasopharyngeal carcinoma.

引文

[1]Heley S.Human papillomavirus:beware the infection you can’t see.Aust Fam Physician,2003,32(5):311-315.
    [2]Burd EM.Human papillomavirus and cervical cancer.Clin Microbiol Rev,2003,16(1):1-17.
    [3]Miyagl J,Kinjo T,Tsuhako K.et a1.Extremely high langerhans cell infiltration contributes t O the favorable prognosis of HPV infected squamous cell carcinoma and adenocarcinoma of the lung.Hist0pathology,2001,38(4):3 55~367.
    [4]Cooper B,Schneider S,Bohl J,et al.Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53[J].Virology,2003,6(1):87-99.
    [5]田野,周本成。引物介导原位标记技术在检测鼻咽癌石蜡切片HPV-DNA的应用。临床与实验病理学杂志,2003,19(2):213-214.
    [6]Riley RR,Duensing S,Brake T,et al.Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis.Cancer Res,2003,63:4862.
    [7]Veldman T,Horikawa I,Barrett JC,et a1.Transcriptional activation of the telomerase h TERT gene by human papillomavirus type 16 E6 oncoprotein.J Viml 200l,75:4467-4472.
    [8]Oh ST.Kyo S.Laimins LA.Telomerase activation by human papillomavirus type 16 E6protein:induction of human telomerase reverse transcriptase expression through Myc and GCrich Spl binding sites.J Virol,2001,75:5559-5566.
    [9]Frost M,Bobak JB,Gianani R,et a1.Localization of telomerase h TERT protein and h TR in benign mucosa,dysplasia and squamous cel1 carcinoma of cervix.Am J Clin Patho1,2000,l14:726-734.
    [10]Kim NW,Piatysezk MA,Prowse KR,et a1.Specific association of human telomerase activity with immortal cells and cancer[J].Science,1994,266:2011—2015.
    [11]Rhyu MS,Telomere,Telomerase and Immortality[J].J Natl Cancer Inst,1995,87(12):844-894.
    [12]Nishi H,Ohyashiki K,Fujito A,et al.Expression of telomerase subunies and localization of telomerase activation in hydatidiform mole[J].Placenta,1999,20(4):317-323.
    [13]Rohde V,Sattler HP,Bund T,el a1.Expression of the human telomerase reverse transcriptase is not related to telom erase activity in normal and malignant renal tissue[J].Clin Cancer Res,2000,6(12):4803—4809.
    [14]Tshikuni N,Nouso K,Higashi T,et a1.Expression of telomerase-associated proteinl and telom erase reverse transcriptase in hepatocellular carcinoma[J].Br J Cancer,2000,82(4):833—837.
    [15]Ku maki F,Kawai T,Hiroi S,a1.Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas[J].Hum Pnthol,2001,32(2):188—195.
    [16]Sumida T,Sogaua K,Hamakanwa H,et a1.Detection of telomerase activity in oral lesions[J].Oral Pathol Med,1998,27:111—115.
    [17]Cheng RY,Yuen PW,Nicholls JM,et al,Telomerase activation in nasopharyngeal carcinoma[J].Br J Cancer,1998,77:456—460.